Shelley George - Vertex Pharmaceuticals, Incorporated

基本信息

浏览量：53

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 36 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Open-Label Study to Evaluate the Safety & Tolerability of Telaprevir in Combination with Sofosbuvir in Naive Subjects Infected with Hepatitis C Virus Genotype 1

Giuseppe Morelli,Roberto Firpi,Patrick Horne,Joy Peter,L Akushevich, Monica Vainorius,Shelley George,A De La Rosa,G Prabhakar Reddy,Taylor J Evers,Richard F Arrendale,Tara L Kieffer, V Garg,Michael W Fried,David R. Nelson

Journal of gastroenterology and hepatology researchno. 5 (2015): 1599-1604

引用0浏览0引用

Open-Label Study to Evaluate the Safety & Tolerability of Telaprevir in Combination with Sofosbuvir in Naive Subjects with HCV Genotype 1 Short Title: Telaprevir & Sofosbuvir in HCV Genotype 1

Giuseppe Morelli, Roberto J. Firpi,Patrick Horne,Joy Peter, Lucy Askushevich,Monika Vainorius,Shelley George, Abel De La Rosa,G. Prabhakar Reddy,Taylor J. Evers,Richard F. Arrendale, Tara L. Kieffer,Varun Garg, Michael Fried,David R. Nelson

Journal of gastroenterology and hepatology researchno. 5 (2015): 1599-1604

引用0浏览0引用

Sustained Virologic Response Rates with Telaprevir-Based Therapy in Treatment-Naive Patients Evaluated by Race or Ethnicity

Steven L Flamm,Andrew J Muir,Michael W Fried,K Rajender Reddy,David R Nelson,Natalie H Bzowej,James C Sullivan,Leif Bengtsson,Ralph DeMasi,Christopher I Wright,Tara L Kieffer,Shelley George,Nathalie Adda,Geoffrey M Dusheiko

Journal of clinical gastroenterology（2015）

引用9浏览0WOS引用

VX-222, a non-nucleoside NS5B polymerase inhibitor, in telaprevir-based regimens for genotype 1 hepatitis C virus infection

Adrian M Di Bisceglie,Mark Sulkowski,Ed Gane,Ira M Jacobson,David Nelson,Cynthia DeSouza,Katia Alves,Shelley George,Tara Kieffer,Eileen Z Zhang,Robert Kauffman,Mohammed Asmal,Margaret J Koziel

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY（2014）

引用9浏览0WOS引用

Resistance to hepatitis C virus protease inhibitors

Tara L Kieffer,Shelley George

Current Opinion in Virology（2014）

引用42浏览0WOS引用

Sustained Virologic Response Rates with Telaprevir by Response after 4weeks of Lead-in Therapy in Patients with Prior Treatment Failure

Graham R. Foster,Stefan Zeuzem,Pietro Andreone,Stanislas Pol,Eric J. Lawitz,Moises Diago,Stuart Roberts,Paul J. Pockros,Zobair Younossi,Isabelle Lonjon-Domanec,Sandra De Meyer,Don Luo,Shelley George,Maria Beumont,Gaston Picchio

Journal of hepatology（2013）

引用19浏览0WOS引用

THERAPIES FOR TREATING HEPATITIS C VIRUS INFECTION

Maria Del Rosario,Nathalie Chauret,Shelley George,Tara L Kieffer,Margaret James Koziel,Olivier Nicolas, L Proulx

mag（2013）

引用23浏览0引用

982 Cost-Effectiveness of First-Line Versus Second-Line Telaprevir Combination Treatment in the Management of Chronic Hepatitis C Virus Infection for Treatment-NaïVE Patients With IL28B Genotype CC

Anita J Brogan,S E Talbird,J R Thompson,J D Miller,Shelley George,Kyle Hvidsten

Gastroenterology（2012）

引用2浏览0引用

VX-222, Telaprevir and Ribavirin in Treatment-Naive Patients with Genotype 1 Chronic Hepatitis C: Results of the ZENITH Study Interferon-Free Regimen

Ira M. Jacobson,Mark S. Sulkowski,Edward J. Gane,Margaret J. Koziel,Cynthia De Souza,Tara L. Kieffer,Marina S. Penney,Eileen Z. Zhang,Shelley George,Robert S. Kauffman,David R. Nelson,Adrian M. Di Bisceglie

HEPATOLOGY（2012）

引用0浏览0引用

The Safety of Telaprevir in the Absence of Interferon and/or Ribavirin: Analysis of On-Treatment Data from the ZENITH Trial

Mark S. Sulkowski,Ira M. Jacobson,Edward J. Gane,Margaret J. Koziel,Cynthia De Souza,Tara L. Kieffer, Lisa G. Benaise,Shelley George,Robert S. Kauffman,David R. Nelson,Adrian M. Di Bisceglie

HEPATOLOGY（2012）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn